Evidence map›Paper›PMID 42559814›Full record

ArticleeLife2026

Pathogen-phage geomapping to overcome resistance.

Camilla Do, Keiko Christine Salazar, James D Chang, Justin R Clark, Austen Lee Terwilliger, Paul Ruchhoeft, Paul Nicholls, Anthony W Maresso

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Camilla DoDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, United States.ORCID https://orcid.org/0000-0002-8798-908X
Keiko Christine SalazarDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, United States.
James D ChangDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, United States.ORCID https://orcid.org/0000-0003-3211-3299
Justin R ClarkDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, United States.ORCID https://orcid.org/0000-0003-1590-6828
Austen Lee TerwilligerDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, United States.ORCID https://orcid.org/0000-0001-8740-0290
Paul RuchhoeftDepartment of Electrical & Computer Engineering, University of Houston, Houston, United States.
Paul NichollsSection of Infection Diseases, Department of Medicine, Baylor College of Medicine, Houston, United States.
Anthony W MaressoDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, United States.ORCID https://orcid.org/0000-0002-4452-3490

Funding

Organoid Cultivation CoreU19AI157981 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI LEMON, KATHERINE PAIGE · 2021 to 2025
$12.4M
Interactions and mechanisms of bacteriophages and antibiotics in phage cocktailsK08AI173452 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI Paul Nicholls · 2024 to 2026
$557k
Baylor College of Medicine Intramural FundsLevy-Longenbaugh Fund PhilanthropicNational Institute of Health Sciences 5 U19 AI157981National Institute of Health Sciences K08 AI173452-01A1National Institute of Health Sciences T32 AI0554413 FellowshipNIAID NIH HHS K08 AI173452NIAID NIH HHS U19 AI157981Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation Philanthropic
6 · The paper itself

Abstract

The rise of antibiotic resistance has renewed interest in bacteriophages as therapeutic alternatives. However, coevolution of phage and bacteria will naturally give rise to phage-resistant pathogens, complicating phage therapy efforts. A critical bottleneck in the production of phage therapeutics is the discovery of virulent phages against resistant pathogens. Conventional methods for discovery are time-consuming, biased, and laborious, limiting the potential for identifying suitable phage candidates. To overcome these limitations, we combined small-volume environmental sampling with 16 S rRNA sequencing to identify reservoirs where bacterial hosts co-exist with their phage predators. This strategy, which we term geographical phage mapping (geΦmapping), pinpoints ecological 'hotspots' for targeted phage hunting. We further developed a portable phage hunting device (ΦHD) that generates highly enriched phage concentrates directly from these reservoirs. By integrating geΦmapping with high-throughput enrichment, we constructed the RΦ library, a diverse collection of novel phages. We captured and isolated 36 new phages targeting extremely resistant organisms across various ESKAPE pathogens when conventional phage hunting and experimental evolution approaches failed.

Indexed as

BacteriaBacteriophagesRNA, Ribosomal, 16SRNA, Ribosomal, 16Sbacteriophagesenterococcus phagesEscherichia phagesinfectious diseaseKlebsiella phagesmicrobiologyPseudomonas phagesviruses

Identifiers

PMID42559814
PMCPMC13446902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.